share_log

醫思健康：截至二零二四年三月三十一日止年度之年度業績公告

EC HEALTHCARE: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2024

Hong Kong Stock Exchange ·  Jun 27 21:50
Summary by Futu AI
医思健康（EC Healthcare）公布截至2024年3月31日止年度業績，總收入達4,211.0百萬港元，同比增長8.7%。醫療服務收入為2,631.9百萬港元，美學醫療及美容及養生服務收入為1,309.4百萬港元，獸醫及其他服務收入為269.7百萬港元。然而，息稅折舊及攤銷前之盈利下降9.8%，純利大幅下跌85.3%至15.7百萬港元。每股基本及攤薄虧損為1.6港仙。期內，公司未宣派末期股息。截至報告期末，公司現金及現金等價物為593.1百萬港元，債務總額為920.7百萬港元，債務總額╱權益比率為38.3%。公司在報告期間進行了戰略審閱，並採取行動以推動可持續利潤增長及提升產能，包括加快新開設的服務點的業務發展，並透過整合重疊及╱或協同業務降低租金成本。展望未來，公司將繼續專注於創新、效率和可持續性，以確保業務在不斷變化的市場中保持競爭力並實現長期增長。
医思健康（EC Healthcare）公布截至2024年3月31日止年度業績，總收入達4,211.0百萬港元，同比增長8.7%。醫療服務收入為2,631.9百萬港元，美學醫療及美容及養生服務收入為1,309.4百萬港元，獸醫及其他服務收入為269.7百萬港元。然而，息稅折舊及攤銷前之盈利下降9.8%，純利大幅下跌85.3%至15.7百萬港元。每股基本及攤薄虧損為1.6港仙。期內，公司未宣派末期股息。截至報告期末，公司現金及現金等價物為593.1百萬港元，債務總額為920.7百萬港元，債務總額╱權益比率為38.3%。公司在報告期間進行了戰略審閱，並採取行動以推動可持續利潤增長及提升產能，包括加快新開設的服務點的業務發展，並透過整合重疊及╱或協同業務降低租金成本。展望未來，公司將繼續專注於創新、效率和可持續性，以確保業務在不斷變化的市場中保持競爭力並實現長期增長。
EC Healthcare announced its performance for the fiscal year ending March 31, 2024, with total revenue of HKD 421.1 million, a year-on-year increase of 8.7%. Medical service revenue was HKD 263.19 million, aesthetic medical, beauty and wellness service revenue was HKD 130.94 million, and veterinary and other service revenue was HKD 26.97 million. However, profit before interest, tax, depreciation, and amortization decreased by 9.8%, and net profit fell sharply by 85.3% to HKD 15.7 million. Basic and diluted loss per share was 1.6 HK cents. The company did not declare a final dividend during the period. As of the end of the reporting period, the company had HKD 593.1 million in cash and cash equivalents, and total debt was HKD 920.7 million. The debt-to-equity ratio was 38.3%. The company conducted...Show More
EC Healthcare announced its performance for the fiscal year ending March 31, 2024, with total revenue of HKD 421.1 million, a year-on-year increase of 8.7%. Medical service revenue was HKD 263.19 million, aesthetic medical, beauty and wellness service revenue was HKD 130.94 million, and veterinary and other service revenue was HKD 26.97 million. However, profit before interest, tax, depreciation, and amortization decreased by 9.8%, and net profit fell sharply by 85.3% to HKD 15.7 million. Basic and diluted loss per share was 1.6 HK cents. The company did not declare a final dividend during the period. As of the end of the reporting period, the company had HKD 593.1 million in cash and cash equivalents, and total debt was HKD 920.7 million. The debt-to-equity ratio was 38.3%. The company conducted a strategic review during the reporting period and took action to promote sustainable profit growth and enhance production capacity, including accelerating the business development of newly opened service points and reducing rental costs through the integration of overlapping and/or synergistic businesses. Looking ahead, the company will continue to focus on innovation, efficiency, and sustainability to ensure that its business remains competitive and achieves long-term growth in a constantly changing market.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.